Investors Contact Careers Research Request

Interpace Biosciences, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
    • Overview
    • Biomarkers Solutions
    • Genomics Services/Molecular Dx
    • Anatomic Path, Flow, and Cytogenetics
    • Integrated Biorepository
    • Bioinformatics Solutions
  • Patients
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan

Jul 31, 2019

Interpace Announces Contract with Blue Shield of California for ThyGeNEXT® & ThyraMIR®

Jul 29, 2019

Interpace Announces New Agreement with SelectHealth

Jul 22, 2019

Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis

Jul 18, 2019

Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners

Jul 15, 2019

Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross

Jun 20, 2019

Interpace Diagnostics Announces Presentation at the World Congress on Thyroid Cancer

Jun 13, 2019

Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update

May 13, 2019

Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week

May 9, 2019

Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results on Monday, May 13, 2019

May 6, 2019
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...20
    © 2021 Interpace Biosciences, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    • Twitter
    • Facebook
    • Linkedin